Gene · 4522
Papers1,437
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,437
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NADPH-Related Enzymes and Cancer: Facts and Insights Into the Application of Immunohistochemistry. | Biochem Res Int | 2026 | 41710542 | PubTator, text mining | PubMed |
| CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1. | Mol Cancer | 2026 | 41668133 | PubTator, text mining | PubMed |
| Hallmarks of nuclear metabolism: implications for genome integrity, nuclear signaling, and therapeutic targeting. | NPJ Metab Health Dis | 2026 | 41629581 | PubTator, text mining | PubMed |
| Isolation and typing techniques for circulating tumor cells. | Biomark Res | 2026 | 41606691 | PubTator, text mining | PubMed |
| Can riboflavin offer a novel personalised strategy for maintaining healthy blood pressure in pregnancy in populations globally? | BMJ Nutr Prev Health | 2025 | 41768514 | PubTator, text mining | PubMed |
| The Multifactorial Causes of Down Syndrome During Pregnancy: A Narrative Review of Genetic, Environmental, and Maternal Influences. | Health Sci Rep | 2025 | 41356612 | PubTator, text mining | PubMed |
| A non-enzymatic role of Nudix hydrolase 5 in repressing purine de novo synthesis. | Science | 2025 | 41196952 | PubTator, text mining | PubMed |
| Extracellular vesicles: cargo loading, degradation and secretory pathways, and their intersection with autophagy. | Extracell Vesicles Circ Nucl Acids | 2025 | 41132500 | PubTator, text mining | PubMed |
| The critical role of methylenetetrahydrofolate dehydrogenases in immune regulation and auto-immunity. | J Inflamm (Lond) | 2025 | 41088269 | PubTator, text mining | PubMed |
| From lactation to malignancy: A comparison between healthy and cancerous breast gland at single-cell resolution reveals new issues for tumorigenesis. | FEBS Lett | 2025 | 40922505 | PubTator, text mining | PubMed |
| IgM and IgG1 B cell receptors differentially affect B cell fates and dictate the pathogenesis of mature B cell lymphomas. | Sci Adv | 2025 | 40880486 | PubTator, text mining | PubMed |
| T cell exhaustion‑related gene CD79B predicts prognosis, inhibits malignant progression and promotes tumor‑associated macrophage M1‑like polarization in lung adenocarcinoma. | Oncol Rep | 2025 | 40878933 | PubTator, text mining | PubMed |
| Viral Reprogramming of Nucleotide Synthesis and Its Impact on Viral Infection. | J Med Virol | 2025 | 40832900 | PubTator, text mining | PubMed |
| Risk factors associated with high-dose methotrexate induced toxicities in primary central nervous system lymphoma. | Front Pharmacol | 2025 | 40832604 | PubTator, text mining | PubMed |
| Modulating the serine metabolism in human differentiated astrocytes: an integrated multi omics approach. | Front Cell Neurosci | 2025 | 40761926 | PubTator, text mining | PubMed |
| New insights into the dule roles CDK12 in human cancers: Mechanisms and interventions for cancer therapy. | J Pharm Anal | 2025 | 40747342 | PubTator, text mining | PubMed |
| Examination of Genetic and Epigenetic Characteristics of Patients with Hyperhomocysteinemia Following High-Dose Folic Acid Consumption. | Nutrients | 2025 | 40647238 | PubTator, text mining | PubMed |
| Analysis of a pan-cancer panel reveals the amino acid metabolism-related gene MTHFD1 as a potential prognostic and immunotherapeutic biomarker. | Exp Ther Med | 2025 | 40462856 | PubTator, text mining | PubMed |
| Impact of Pharmacogenetics on High-Dose Methotrexate Toxicity in Pediatric Oncology. | Pharmaceutics | 2025 | 40430876 | PubTator, text mining | PubMed |
| Dimethyl fumarate abrogates hepatocellular carcinoma growth by inhibiting Nrf2/Bcl-xL axis and enhances sorafenib's efficacy. | Sci Rep | 2025 | 40369009 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4522/papers?page=2